Is Glimepiride a Safer Sulfonylurea for Type 2 Diabetes?

Observational data show that certain types of sulfonylureas for the treatment of type 2 diabetes are associated with more cardiovascular events compared to other types, such as glimepiride.

Related Keywords

Taipei ,T Ai Pei ,Taiwan ,United States ,Belgium ,American ,Taiwanese ,Roberta Gabbay ,Eli Lilly ,Glaxosmithkline ,Vida Health ,Division Of Diabetes ,Boehringer Ingelheim ,American Diabetes Association ,Startup Health ,Novartis ,Taiwan Diabetes Mellitus Health Database ,Astrazeneca ,Health Reveal ,Novo Nordisk ,Meng Ting Wang ,Metabolic Disorders ,Academic Hospital ,Affinity Sulfonylureas Predominate ,Diabetes Care ,Merck Sharp ,Diabetes Mellitus Type 2 ,Iabetes Mellitus Type Ii ,Type 2 Diabetes ,Sulfonylureas ,Infarct ,Infarction ,Myocardial Infarction ,Hypoglycemia ,Match ,Match Day ,Watch Application ,Atch Medical Students ,Sglt2 Inhibitors ,Odium Glucose Transporter 2 Inhibitors ,Odium Glucose Co Transporter 2 Inhibitors ,Sodium Glucose Cotransporter 2 Inhibitors ,Stroke ,Erebrovascular Accident ,Va Cerebrovascular ,